Contrarian Capital Management’s Braskem BAK Stock Holding History
Bought
Maintained
Sold
Other funds holding BAK
OCM
Contrarian Capital Management's BAK Position: Q4 2020 in Review
Contrarian Capital Management sold out of Braskem (BAK) in Q4 2020, closing a stake of 3,091,118 shares — an estimated $23.1M sold.
Contrarian Capital Management first reported a position in BAK in Q3 2016 and held it in 15 quarters. The position peaked at $96.3M in Q3 2018. 34 funds tracked by Wall St. Rank hold BAK as of Q4 2020.
- Contrarian Capital Management reported no remaining Braskem position as of Q4 2020 after selling out during the quarter.
- Contrarian Capital Management sold 3,091,118 Braskem shares in Q4 2020, an estimated $23.1M.
- Contrarian Capital Management first reported a position in Braskem in Q3 2016 and held it in 15 quarters.
- Contrarian Capital Management's Braskem position peaked at $96.3M in Q3 2018.
- 34 funds tracked by Wall St. Rank held Braskem as of Q4 2020.
Based on Contrarian Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.